Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs Gross Margin 2010-2025 | PRPH

Current and historical gross margin for ProPhase Labs (PRPH) over the last 10 years. The current gross profit margin for ProPhase Labs as of March 31, 2025 is %.
  
ProPhase Labs Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.01B $0.00B 40.00%
2024-12-31 $0.01B $0.00B 16.67%
2024-09-30 $0.00B $0.00B -400.00%
2024-06-30 $0.01B $0.00B -33.33%
2024-03-31 $0.02B $0.00B 23.53%
2023-12-31 $0.03B $0.02B 44.12%
2023-09-30 $0.06B $0.03B 48.39%
2023-06-30 $0.08B $0.04B 51.28%
2023-03-31 $0.09B $0.05B 56.38%
2022-12-31 $0.12B $0.07B 57.72%
2022-09-30 $0.15B $0.09B 58.22%
2022-06-30 $0.13B $0.08B 58.78%
2022-03-31 $0.11B $0.06B 55.86%
2021-12-31 $0.08B $0.04B 53.85%
2021-09-30 $0.04B $0.02B 50.00%
2021-06-30 $0.03B $0.02B 48.48%
2021-03-31 $0.03B $0.01B 46.43%
2020-12-31 $0.02B $0.00B 26.67%
2020-09-30 $0.01B $0.00B 23.08%
2020-06-30 $0.01B $0.00B 25.00%
2020-03-31 $0.01B $0.00B 20.00%
2019-12-31 $0.01B $0.00B 30.00%
2019-09-30 $0.01B $0.00B 27.27%
2019-06-30 $0.01B $0.00B 30.00%
2019-03-31 $0.01B $0.00B 36.36%
2018-12-31 $0.01B $0.00B 33.33%
2018-09-30 $0.01B $0.00B 33.33%
2018-06-30 $0.01B $0.00B 23.08%
2018-03-31 $0.01B $0.00B 16.67%
2017-12-31 $0.01B $0.00B 10.00%
2017-09-30 $0.01B 0 0.00%
2017-06-30 $0.01B 0 0.00%
2017-03-31 $0.00B 0 0.00%
2016-12-31 $0.00B 0 0.00%
2016-09-30 $-0.01B $-0.01B 100.00%
2016-06-30 $0.00B $0.00B 100.00%
2016-03-31 $0.00B $0.00B 100.00%
2015-12-31 $0.00B $0.00B 50.00%
2015-09-30 $0.02B $0.01B 66.67%
2015-06-30 $0.02B $0.02B 68.18%
2015-03-31 $0.02B $0.02B 68.18%
2014-12-31 $0.02B $0.02B 68.18%
2014-09-30 $0.02B $0.02B 69.57%
2014-06-30 $0.02B $0.02B 66.67%
2014-03-31 $0.02B $0.02B 66.67%
2013-12-31 $0.03B $0.02B 65.38%
2013-09-30 $0.03B $0.02B 64.00%
2013-06-30 $0.02B $0.02B 62.50%
2013-03-31 $0.02B $0.02B 62.50%
2012-12-31 $0.02B $0.01B 63.64%
2012-09-30 $0.02B $0.01B 65.00%
2012-06-30 $0.02B $0.01B 70.00%
2012-03-31 $0.02B $0.01B 70.00%
2011-12-31 $0.02B $0.01B 70.59%
2011-09-30 $0.02B $0.01B 68.75%
2011-06-30 $0.02B $0.01B 68.75%
2011-03-31 $0.02B $0.01B 66.67%
2010-12-31 $0.01B $0.01B 64.29%
2010-09-30 $0.02B $0.01B 58.82%
2010-06-30 $0.02B $0.01B 58.82%
2010-03-31 $0.02B $0.01B 55.56%
2009-12-31 $0.02B $0.01B 55.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.015B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.131B 31.18
Zoetis (ZTS) United States $71.977B 26.85
Takeda Pharmaceutical (TAK) Japan $47.379B 9.42
Daiichi Sankyo, - (DSNKY) Japan $45.180B 23.16
BeOne Medicines - (ONC) Cayman Islands $27.838B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.876B 0.00
Merck (MKKGY) Germany $16.572B 12.14
Summit Therapeutics (SMMT) United States $14.742B 0.00
Shionogi (SGIOY) Japan $14.496B 14.52
United Therapeutics (UTHR) United States $12.940B 11.45
Neurocrine Biosciences (NBIX) United States $12.359B 42.33
Orion OYJ (ORINY) Finland $10.283B 27.81
IPSEN (IPSEY) France $10.093B 0.00
Corcept Therapeutics (CORT) United States $7.619B 61.94
Stevanato Group S.p.A (STVN) Italy $7.299B 44.63
Madrigal Pharmaceuticals (MDGL) United States $6.208B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.754B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.911B 0.00
Hypermarcas (HYPMY) Brazil $3.177B 20.90
Crinetics Pharmaceuticals (CRNX) United States $2.888B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.832B 9.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.476B 13.39
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.967B 0.00
Indivior (INDV) United States $1.899B 8.05
Centessa Pharmaceuticals (CNTA) United Kingdom $1.683B 0.00
ARS Pharmaceuticals (SPRY) United States $1.456B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.322B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.234B 0.00
Harrow (HROW) United States $1.116B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.069B 21.38
Verve Therapeutics (VERV) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $0.946B 5.10
Akebia Therapeutics (AKBA) United States $0.919B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.906B 0.00
Ardelyx (ARDX) United States $0.849B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.710B 0.00
KalVista Pharmaceuticals (KALV) United States $0.604B 0.00
Xencor (XNCR) United States $0.591B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.33
Altimmune (ALT) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.530B 0.00
Relay Therapeutics (RLAY) United States $0.525B 0.00
Bioventus (BVS) United States $0.522B 13.23
AleAnna (ANNA) United States $0.491B 0.00
Zevra Therapeutics (ZVRA) United States $0.482B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.475B 0.00
Tourmaline Bio (TRML) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.450B 9.40
Oruka Therapeutics (ORKA) United States $0.448B 0.00
Organogenesis (ORGO) United States $0.397B 0.00
Savara (SVRA) United States $0.353B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 9.26
Liminatus Pharma (LIMN) United States $0.333B 0.00
Aquestive Therapeutics (AQST) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.22
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
ProKidney (PROK) United States $0.251B 0.00
Nanobiotix S.A (NBTX) France $0.217B 0.00
Esperion Therapeutics (ESPR) United States $0.216B 0.00
MediWound (MDWD) Israel $0.214B 0.00
OmniAb (OABI) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.192B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Aclaris Therapeutics (ACRS) United States $0.152B 0.00
Galectin Therapeutics (GALT) United States $0.151B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.151B 0.00
Journey Medical (DERM) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Avita Medical (RCEL) United States $0.138B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Korro Bio (KRRO) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.111B 18.30
Nektar Therapeutics (NKTR) United States $0.108B 0.00
Achieve Life Sciences (ACHV) Canada $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Wellgistics Health (WGRX) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.087B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Surrozen (SRZN) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Telomir Pharmaceuticals (TELO) United States $0.055B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
Jupiter Neurosciences (JUNS) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
FibroGen (FGEN) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
CERo Therapeutics Holdings (CERO) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00